Focus: ClearPoint Neuro develops minimally invasive surgical devices guided by intra-procedural MRI for brain and heart interventions, positioning itself in the high-precision neurosurgical device market. The company operates at modest scale with 5 active job openings and focuses on critical care applications.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Stable — net -1 jobs in 30d
2 added, 3 removed. Backfill posture.
ClearPoint Neuro offers specialized device engineering experience and international growth, but minimal hiring and undisclosed financials create career risk for those seeking scale, visibility, or advancement.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ClearPoint Neuro
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ClearPoint Neuro's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles